CVS Group in UK is the largest vet service provider with 460+ sites with EBITDA ~$50M for 2018 and enterprise value is GBP 776M, implying a trading valuation of 15.5 x EBITDA, a much higher valuation than NVL. I am now more than convinced that GXL is definitely undervalued.
GXL Target Price of $8.03/share, page-5
-
- There are more pages in this discussion • 162 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
